Kimberly Yonkers to Randomized Controlled Trials as Topic
This is a "connection" page, showing publications Kimberly Yonkers has written about Randomized Controlled Trials as Topic.
Connection Strength
0.530
-
Ondersma SJ, Todd L, Jablonski S, Ahuja C, Gilstad-Hayden K, Goyert G, Loree A, Heffner J, Yonkers KA. Online randomised factorial trial of electronic Screening and Brief Intervention for alcohol use in pregnancy: a study protocol. BMJ Open. 2022 08 03; 12(8):e062735.
Score: 0.157
-
Loree AM, Gariepy A, Ruger JP, Yonkers KA. Postpartum Contraceptive use and Rapid Repeat Pregnancy Among Women who use Substances. Subst Use Misuse. 2018 01 02; 53(1):162-169.
Score: 0.112
-
Yonkers KA, Howell HB, Allen AE, Ball SA, Pantalon MV, Rounsaville BJ. A treatment for substance abusing pregnant women. Arch Womens Ment Health. 2009 Aug; 12(4):221-7.
Score: 0.062
-
Steiner M, Pearlstein T, Cohen LS, Endicott J, Kornstein SG, Roberts C, Roberts DL, Yonkers K. Expert guidelines for the treatment of severe PMS, PMDD, and comorbidities: the role of SSRIs. J Womens Health (Larchmt). 2006 Jan-Feb; 15(1):57-69.
Score: 0.050
-
Yonkers KA. Management strategies for PMS/PMDD. J Fam Pract. 2004 Sep; Suppl:S15-20.
Score: 0.045
-
Wong AH, Nath B, Shah D, Kumar A, Brinker M, Faustino IV, Boyce M, Dziura JD, Heckmann R, Yonkers KA, Bernstein SL, Adapa K, Taylor RA, Ovchinnikova P, McCall T, Melnick ER. Formative evaluation of an emergency department clinical decision support system for agitation symptoms: a study protocol. BMJ Open. 2024 02 19; 14(2):e082834.
Score: 0.044
-
Yonkers KA, Clark RH, Trivedi MH. The psychopharmacological treatment of nonmajor mood disorders. Mod Probl Pharmacopsychiatry. 1997; 25:146-66.
Score: 0.027
-
Cole-Lewis HJ, Kershaw TS, Earnshaw VA, Yonkers KA, Lin H, Ickovics JR. Pregnancy-specific stress, preterm birth, and gestational age among high-risk young women. Health Psychol. 2014 Sep; 33(9):1033-45.
Score: 0.022
-
Halbreich U, O'Brien PM, Eriksson E, B?ckstr?m T, Yonkers KA, Freeman EW. Are there differential symptom profiles that improve in response to different pharmacological treatments of premenstrual syndrome/premenstrual dysphoric disorder? CNS Drugs. 2006; 20(7):523-47.
Score: 0.012